# Progress Note 05 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Paul Robeson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML048-SYN-TD
- Date: 1957-07-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Theodore Bankole-Ashworth, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Cough for five days after a cold. **S**

## History of present illness

Mr. Robeson called this morning and was seen the same day. A week ago he had a sore throat and a runny nose, and for five days he has had a cough, worse at night, with a little clear sputum. He has had no fever, breathlessness, chest pain or blood in the sputum. The cough is keeping him awake and he wants to protect his voice. He bought a nighttime cold medicine but did not take it after reading that it contained dextromethorphan and remembering the warning about venlafaxine. He takes venlafaxine 225 mg each morning, three weeks at the full dose, with mild sweating and no other side effects. His mood is a little better than in the spring; he goes to his therapy sessions each week and walks most mornings. He has had no thoughts of suicide or of being better off dead. **S**

| Element | Detail |
|---|---|
| Onset | Cough for five days after a cold a week ago |
| Character | Cough with a little clear sputum, worse at night |
| Severity | Disturbing his sleep; no breathlessness |
| Context | Venlafaxine 225 mg daily; has avoided a dextromethorphan cold remedy |
| Associated signs and symptoms | No fever, chest pain or blood in the sputum |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or chills; tired from broken sleep |
| Ears, nose, mouth, and throat | Positive | Sore throat and runny nose last week, now settling; voice a little hoarse |
| Respiratory | Positive | Cough with clear sputum; no wheeze, breathlessness or hemoptysis |
| Cardiovascular | Negative | No chest pain or palpitations |
| Psychiatric | Positive | Mood low but improving; no thoughts of suicide |

5 systems reviewed. **S**

## Current medications

- Venlafaxine extended-release 75 mg capsules, three capsules (225 mg) each morning with food **S**

## Allergies

- No known allergy **S**

## Objective

BP 132/82 mmHg; pulse 84 bpm; respirations 16/min; temperature 37.4 °C; oxygen saturation 97% on room air; weight 100.6 kg; BMI 27.9 kg/m². All vital signs are synthetic.

No condition-specific results recorded.

## Physical examination

| System | Finding |
|---|---|
| General | Comfortable; temperature 37.4 °C, pulse 84, respiratory rate 16, oxygen saturation 97 percent, blood pressure 132/82 |
| Ears, nose, mouth, and throat | Mild pharyngeal redness; no exudate; ears normal |
| Respiratory | Scattered rhonchi that clear with coughing; no crackles, wheeze or bronchial breathing |
| Cardiovascular | Regular rhythm |
| Psychiatric | Calm, brighter than in the spring; no thoughts of suicide |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute bronchitis** (J20.9). Acute bronchitis after a viral cold. Pulse under 100, respiratory rate under 24, temperature under 38 °C and a normal chest examination make pneumonia unlikely, so no chest X-ray or antibiotic is needed; the cough may last two to three weeks. He was right to avoid the dextromethorphan remedy: with venlafaxine it can cause serotonin syndrome. Decongestants are also avoided because venlafaxine can raise blood pressure. **S**
   - Honey in warm drinks, steam and fluids; rest the voice.
   - Plain guaifenesin if the sputum is thick; read labels for dextromethorphan, pseudoephedrine and phenylephrine.
   - Return for fever, breathlessness, chest pain, blood in the sputum, or a cough lasting more than three weeks.
2. **Recurrent major depression on venlafaxine** (F33.2). Three weeks at 225 mg. Safety reviewed: no thoughts of suicide or of being better off dead; medicines kept in the locked box; the 988 Suicide & Crisis Lifeline is in his phone. Blood pressure 132/82. **S**
   - Continue venlafaxine 225 mg and weekly behavioral activation.
   - Review in four weeks as booked.

## Guideline basis

- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), U.S. Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), U.S. Department of Veterans Affairs and Department of Defense
- Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016), American College of Physicians and Centers for Disease Control and Prevention (Annals of Internal Medicine)

## Follow-up

- Twenty-four-week review in four weeks as booked. Return sooner for fever or breathlessness. Call or text 988 at any time in a crisis. **S**
- Next scheduled visit 1957-08-24: twenty-four-week review: partial response to venlafaxine; treatment-resistant depression; aripiprazole augmentation and an informed consent discussion about ECT. **S**
